AMERICAN BIO MEDICA CORP Quarterly Debt-to-equity in % from Q1 2012 to Q1 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
American Bio Medica Corp quarterly Debt-to-equity history and growth rate from Q1 2012 to Q1 2023.
  • American Bio Medica Corp Debt-to-equity for the quarter ending March 31, 2023 was -167 %, a 37% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2023 -167 +98 +37% Mar 31, 2023
Q4 2022 -171 +93.4 +35.3% Dec 31, 2022
Q3 2022 -198 +56.9 +22.3% Sep 30, 2022
Q2 2022 -249 -11.5 -4.83% Jun 30, 2022
Q1 2022 -265 +4.91 +1.82% Mar 31, 2022
Q4 2021 -265 +52.8 +16.6% Dec 31, 2021
Q3 2021 -255 +94.2 +27% Sep 30, 2021
Q2 2021 -237 +165 +41% Jun 30, 2021
Q1 2021 -270 +180 +40.1% Mar 31, 2021
Q4 2020 -318 +194 +37.9% Dec 31, 2020
Q3 2020 -349 +366 +51.2% Sep 30, 2020
Q2 2020 -403 +820 +67.1% Jun 30, 2020
Q1 2020 -450 +4.52K +90.9% Mar 31, 2020
Q4 2019 -512 -2.47K -126% Dec 31, 2019
Q3 2019 -716 -1.49K -193% Sep 30, 2019
Q2 2019 -1.22K -1.68K -367% Jun 30, 2019
Q1 2019 -4.97K -5.31K -1572% Mar 31, 2019
Q4 2018 1.96K +1.68K +599% Dec 31, 2018
Q3 2018 773 +521 +208% Sep 30, 2018
Q2 2018 458 +225 +96.4% Jun 30, 2018
Q1 2018 338 +110 +48.2% Mar 31, 2018
Q4 2017 280 +59.9 +27.3% Dec 31, 2017
Q3 2017 251 +19.6 +8.45% Sep 30, 2017
Q2 2017 233 -15.5 -6.24% Jun 30, 2017
Q1 2017 228 -35.6 -13.5% Mar 31, 2017
Q4 2016 220 -49.2 -18.3% Dec 31, 2016
Q3 2016 232 -45.3 -16.3% Sep 30, 2016
Q2 2016 249 -27.6 -9.98% Jun 30, 2016
Q1 2016 263 +3.88 +1.5% Mar 31, 2016
Q4 2015 269 +10.7 +4.14% Dec 31, 2015
Q3 2015 277 +26.8 +10.7% Sep 30, 2015
Q2 2015 276 -6.67 -2.36% Jun 30, 2015
Q1 2015 260 -73 -22% Mar 31, 2015
Q4 2014 258 -95.5 -27% Dec 31, 2014
Q3 2014 250 -96.8 -27.9% Sep 30, 2014
Q2 2014 283 +4.8 +1.73% Jun 30, 2014
Q1 2014 333 +108 +48% Mar 31, 2014
Q4 2013 354 +161 +83.5% Dec 31, 2013
Q3 2013 347 +178 +106% Sep 30, 2013
Q2 2013 278 +121 +77.4% Jun 30, 2013
Q1 2013 225 +76 +51.1% Mar 31, 2013
Q4 2012 193 Dec 31, 2012
Q3 2012 168 Sep 30, 2012
Q2 2012 157 Jun 30, 2012
Q1 2012 149 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.